Boill Healthcare Holdings Limited provided earnings guidance for the year ended March 31, 2018. The board of directors of the company informed the shareholders of the Company and potential investors that the Group is expected to record a significant decrease in the consolidated net loss for the year ended 31 March 2018 based on the Board's preliminary review of the unaudited consolidated management accounts for the year ended 31 March 2018. The consolidated net loss attributable to owners of the Company for the year ended 31 March 2018 may be further increased if there is any written down value of the property under development or the completed properties held for sale. The Board considers that the significant unaudited consolidated net loss for the current year was mainly due to the following: The net loss incurred by the foundation piling business in the current year was mainly attributable to the discounts offered for the tendered projects to deal with the intense competition with other subcontractors in the tender, which led to decreasing turnover. However, the fixed costs (including depreciation and salaries) did not decrease together with the turnover, and thus affected the overall results; The net loss incurred by the property development business in the current year as the Group expedited the sale of the commercial and residential properties by offering big discounts on the selling price in order to generate cash flow for the repayment of loan to financial institution; The construction of the project relating to the newly acquired Shanghai Jin Sheng Long Real Estate Co. Ltd. in April 2017 is still under construction and no revenue has been recognised but the cost incurred for daily operation was not less than HKD 19 million for the year ended 31 March 2018; The significant interest expenses on borrowings were approximately HKD 93.87 million (2017: HKD 127.89 million); and Although the Group recorded a realised gain and unrealised gain on the equity investments at fair value through profit or loss approximately HKD 58.07 million (2017: realised loss HKD 51.06 million) and HKD 6.04 million (2017: unrealised loss HKD 143.11 million) respectively.